A Novel Treatment Modality for Malignant Peripheral Nerve Sheath Tumor Using a Dual-Effect Liposome to Combine Photodynamic Therapy and Chemotherapy

A Novel Treatment Modality for Malignant Peripheral Nerve Sheath Tumor Using a Dual-Effect Liposome to Combine Photodynamic Therapy and Chemotherapy

Neurofibromatosis type 1 (NF1) is an inherited neurological disorder. Approximately 5–13% of NF1 patients may develop a malignant peripheral nerve sheath tumor (MPNST), which is a neurofibrosarcoma transformed from the plexiform neurofibroma or schwannoma. Given the large size and easy metastasis of...

Full description

Bibliographic Details
Main Authors: Chin-Tin Chen, Po-Chun Peng, Tsuimin Tsai, Hsiung-Fei Chien, Ming-Jen Lee
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Pharmaceutics
Subjects:
NF1
plexiform neurofibroma
MPNST
chemotherapy
liposome
Online Access:https://www.mdpi.com/1999-4923/12/4/317
id doaj-1325de8dbea04e098fc6ce94f437e2fa
record_format Article
spelling doaj-1325de8dbea04e098fc6ce94f437e2fa2020-11-25T02:04:02ZengMDPI AGPharmaceutics1999-49232020-04-011231731710.3390/pharmaceutics12040317A Novel Treatment Modality for Malignant Peripheral Nerve Sheath Tumor Using a Dual-Effect Liposome to Combine Photodynamic Therapy and ChemotherapyChin-Tin Chen0Po-Chun Peng1Tsuimin Tsai2Hsiung-Fei Chien3Ming-Jen Lee4Department of Biochemical Science and Technology, National Taiwan University, No. 1, Sec. 4, Roosevelt Road, Taipei 10617, TaiwanDepartment of Biochemical Science and Technology, National Taiwan University, No. 1, Sec. 4, Roosevelt Road, Taipei 10617, TaiwanGraduate Institute of Biomedical Materials and Engineering, Graduate School of Dentistry, Taipei Medical University, Taipei 11043, TaiwanDivision of Plastic Surgery, Department of Surgery, Taipei Medical University Hospital and College of Medicine, Taipei Medical University, Taipei 110, TaiwanDepartment of Neurology, National Taiwan University Hospital, 7, Chung-Shan South Road, Taipei 10012, TaiwanNeurofibromatosis type 1 (NF1) is an inherited neurological disorder. Approximately 5–13% of NF1 patients may develop a malignant peripheral nerve sheath tumor (MPNST), which is a neurofibrosarcoma transformed from the plexiform neurofibroma or schwannoma. Given the large size and easy metastasis of MPNST, it remains difficult to be cured by either surgical or conventional chemotherapy. In this study, we investigated the possibility of combining photodynamic therapy (PDT) and chemotherapy to treat MPNST by using a dual-effect liposome (named as PL-cDDP-Ce6), in which a chemotherapeutic agent, cisplatin (cDDP), and photosensitizer, chlorine e6 (Ce6) were encapsulated in the same carrier. The cytotoxic effect of PL-cDDP-Ce6 against MPNST cells was significantly higher than cells treated with liposomal cDDP or Ce6 alone or in combination after light irradiation. Treatment with the dual-effect liposomes in mice bearing xenograft MPNST tumor reveals a significant increase in survival rate compared to those treated with liposomal cDDP and Ce6 in combination. Moreover, there is no weight loss or derangements of serum biochemistry. In conclusion, this study demonstrates the clinical potential and advantage of using this liposomal drug for the treatment of MPNST.https://www.mdpi.com/1999-4923/12/4/317NF1plexiform neurofibromaMPNSTchemotherapyliposome
collection DOAJ
language English
format Article
sources DOAJ
author Chin-Tin Chen
Po-Chun Peng
Tsuimin Tsai
Hsiung-Fei Chien
Ming-Jen Lee
spellingShingle Chin-Tin Chen
Po-Chun Peng
Tsuimin Tsai
Hsiung-Fei Chien
Ming-Jen Lee
A Novel Treatment Modality for Malignant Peripheral Nerve Sheath Tumor Using a Dual-Effect Liposome to Combine Photodynamic Therapy and Chemotherapy
Pharmaceutics
NF1
plexiform neurofibroma
MPNST
chemotherapy
liposome
author_facet Chin-Tin Chen
Po-Chun Peng
Tsuimin Tsai
Hsiung-Fei Chien
Ming-Jen Lee
author_sort Chin-Tin Chen
title A Novel Treatment Modality for Malignant Peripheral Nerve Sheath Tumor Using a Dual-Effect Liposome to Combine Photodynamic Therapy and Chemotherapy
title_short A Novel Treatment Modality for Malignant Peripheral Nerve Sheath Tumor Using a Dual-Effect Liposome to Combine Photodynamic Therapy and Chemotherapy
title_full A Novel Treatment Modality for Malignant Peripheral Nerve Sheath Tumor Using a Dual-Effect Liposome to Combine Photodynamic Therapy and Chemotherapy
title_fullStr A Novel Treatment Modality for Malignant Peripheral Nerve Sheath Tumor Using a Dual-Effect Liposome to Combine Photodynamic Therapy and Chemotherapy
title_full_unstemmed A Novel Treatment Modality for Malignant Peripheral Nerve Sheath Tumor Using a Dual-Effect Liposome to Combine Photodynamic Therapy and Chemotherapy
title_sort novel treatment modality for malignant peripheral nerve sheath tumor using a dual-effect liposome to combine photodynamic therapy and chemotherapy
publisher MDPI AG
series Pharmaceutics
issn 1999-4923
publishDate 2020-04-01
description Neurofibromatosis type 1 (NF1) is an inherited neurological disorder. Approximately 5–13% of NF1 patients may develop a malignant peripheral nerve sheath tumor (MPNST), which is a neurofibrosarcoma transformed from the plexiform neurofibroma or schwannoma. Given the large size and easy metastasis of MPNST, it remains difficult to be cured by either surgical or conventional chemotherapy. In this study, we investigated the possibility of combining photodynamic therapy (PDT) and chemotherapy to treat MPNST by using a dual-effect liposome (named as PL-cDDP-Ce6), in which a chemotherapeutic agent, cisplatin (cDDP), and photosensitizer, chlorine e6 (Ce6) were encapsulated in the same carrier. The cytotoxic effect of PL-cDDP-Ce6 against MPNST cells was significantly higher than cells treated with liposomal cDDP or Ce6 alone or in combination after light irradiation. Treatment with the dual-effect liposomes in mice bearing xenograft MPNST tumor reveals a significant increase in survival rate compared to those treated with liposomal cDDP and Ce6 in combination. Moreover, there is no weight loss or derangements of serum biochemistry. In conclusion, this study demonstrates the clinical potential and advantage of using this liposomal drug for the treatment of MPNST.
topic NF1
plexiform neurofibroma
MPNST
chemotherapy
liposome
url https://www.mdpi.com/1999-4923/12/4/317
work_keys_str_mv AT chintinchen anoveltreatmentmodalityformalignantperipheralnervesheathtumorusingadualeffectliposometocombinephotodynamictherapyandchemotherapy
AT pochunpeng anoveltreatmentmodalityformalignantperipheralnervesheathtumorusingadualeffectliposometocombinephotodynamictherapyandchemotherapy
AT tsuimintsai anoveltreatmentmodalityformalignantperipheralnervesheathtumorusingadualeffectliposometocombinephotodynamictherapyandchemotherapy
AT hsiungfeichien anoveltreatmentmodalityformalignantperipheralnervesheathtumorusingadualeffectliposometocombinephotodynamictherapyandchemotherapy
AT mingjenlee anoveltreatmentmodalityformalignantperipheralnervesheathtumorusingadualeffectliposometocombinephotodynamictherapyandchemotherapy
AT chintinchen noveltreatmentmodalityformalignantperipheralnervesheathtumorusingadualeffectliposometocombinephotodynamictherapyandchemotherapy
AT pochunpeng noveltreatmentmodalityformalignantperipheralnervesheathtumorusingadualeffectliposometocombinephotodynamictherapyandchemotherapy
AT tsuimintsai noveltreatmentmodalityformalignantperipheralnervesheathtumorusingadualeffectliposometocombinephotodynamictherapyandchemotherapy
AT hsiungfeichien noveltreatmentmodalityformalignantperipheralnervesheathtumorusingadualeffectliposometocombinephotodynamictherapyandchemotherapy
AT mingjenlee noveltreatmentmodalityformalignantperipheralnervesheathtumorusingadualeffectliposometocombinephotodynamictherapyandchemotherapy
_version_ 1724944988678127616

Similar Items